Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population

L. Vallo, E. Bonifazi, P. Borgiani, G. Novelli, A. Botta

Research output: Contribution to journalArticle

Abstract

Myotonic dystrophy type 2 (DM2) is a dominant inherited disorder clinically similar to myotonic dystrophy type 1 (DM1) with a peculiar pattern of multisystemic phenotypic features. The mutation responsible for DM1 is a CTG repeat in the 3′ UTR of the dystrophia myotonica protein kinase gene (DMPK) on chromosome 19q13.3, while DM2 is caused by an unstable CCTG expansion in intron 1 of the zinc finger protein 9 gene (ZNF9) on chromosome 3q21.3. Southern blotting analysis is the conventional test used to determinate the size of the repeats in the molecular diagnosis of DM2. However, the large number of CCTG repeats and their somatic instability complicates this diagnostic protocol. In order to improve the DM2 test, we have recently characterised a single nucleotide polymorphism located in the first intron of the ZNF9 gene. This SNP consists in a C to A nucleotide change, which creates or disrupts and ApaI enzyme restriction site, easily detectable by PCR amplification followed by restriction analysis. We genotyped this SNP in 30 unrelated DM2 patients and 70 unrelated Italians healthy individuals. Our results show that this polymorphism is in linkage disequilibrium with the DM2 mutation.

Original languageEnglish
Pages (from-to)71-74
Number of pages4
JournalMolecular and Cellular Probes
Volume19
Issue number1
DOIs
Publication statusPublished - Feb 2005

Fingerprint

Myotonic Dystrophy
Zinc Fingers
Single Nucleotide Polymorphism
Introns
Chromosomes
Population
Genes
Mutation
Proteins
Linkage Disequilibrium
3' Untranslated Regions
Southern Blotting
Protein Kinases
Nucleotides
Polymerase Chain Reaction
Enzymes

Keywords

  • Molecular diagnosis
  • Myotonic dystrophy
  • ZNF9

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population. / Vallo, L.; Bonifazi, E.; Borgiani, P.; Novelli, G.; Botta, A.

In: Molecular and Cellular Probes, Vol. 19, No. 1, 02.2005, p. 71-74.

Research output: Contribution to journalArticle

@article{0587f5c6a2fb4da090d489e0b3a8116a,
title = "Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population",
abstract = "Myotonic dystrophy type 2 (DM2) is a dominant inherited disorder clinically similar to myotonic dystrophy type 1 (DM1) with a peculiar pattern of multisystemic phenotypic features. The mutation responsible for DM1 is a CTG repeat in the 3′ UTR of the dystrophia myotonica protein kinase gene (DMPK) on chromosome 19q13.3, while DM2 is caused by an unstable CCTG expansion in intron 1 of the zinc finger protein 9 gene (ZNF9) on chromosome 3q21.3. Southern blotting analysis is the conventional test used to determinate the size of the repeats in the molecular diagnosis of DM2. However, the large number of CCTG repeats and their somatic instability complicates this diagnostic protocol. In order to improve the DM2 test, we have recently characterised a single nucleotide polymorphism located in the first intron of the ZNF9 gene. This SNP consists in a C to A nucleotide change, which creates or disrupts and ApaI enzyme restriction site, easily detectable by PCR amplification followed by restriction analysis. We genotyped this SNP in 30 unrelated DM2 patients and 70 unrelated Italians healthy individuals. Our results show that this polymorphism is in linkage disequilibrium with the DM2 mutation.",
keywords = "Molecular diagnosis, Myotonic dystrophy, ZNF9",
author = "L. Vallo and E. Bonifazi and P. Borgiani and G. Novelli and A. Botta",
year = "2005",
month = "2",
doi = "10.1016/j.mcp.2004.09.003",
language = "English",
volume = "19",
pages = "71--74",
journal = "Molecular and Cellular Probes",
issn = "0890-8508",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population

AU - Vallo, L.

AU - Bonifazi, E.

AU - Borgiani, P.

AU - Novelli, G.

AU - Botta, A.

PY - 2005/2

Y1 - 2005/2

N2 - Myotonic dystrophy type 2 (DM2) is a dominant inherited disorder clinically similar to myotonic dystrophy type 1 (DM1) with a peculiar pattern of multisystemic phenotypic features. The mutation responsible for DM1 is a CTG repeat in the 3′ UTR of the dystrophia myotonica protein kinase gene (DMPK) on chromosome 19q13.3, while DM2 is caused by an unstable CCTG expansion in intron 1 of the zinc finger protein 9 gene (ZNF9) on chromosome 3q21.3. Southern blotting analysis is the conventional test used to determinate the size of the repeats in the molecular diagnosis of DM2. However, the large number of CCTG repeats and their somatic instability complicates this diagnostic protocol. In order to improve the DM2 test, we have recently characterised a single nucleotide polymorphism located in the first intron of the ZNF9 gene. This SNP consists in a C to A nucleotide change, which creates or disrupts and ApaI enzyme restriction site, easily detectable by PCR amplification followed by restriction analysis. We genotyped this SNP in 30 unrelated DM2 patients and 70 unrelated Italians healthy individuals. Our results show that this polymorphism is in linkage disequilibrium with the DM2 mutation.

AB - Myotonic dystrophy type 2 (DM2) is a dominant inherited disorder clinically similar to myotonic dystrophy type 1 (DM1) with a peculiar pattern of multisystemic phenotypic features. The mutation responsible for DM1 is a CTG repeat in the 3′ UTR of the dystrophia myotonica protein kinase gene (DMPK) on chromosome 19q13.3, while DM2 is caused by an unstable CCTG expansion in intron 1 of the zinc finger protein 9 gene (ZNF9) on chromosome 3q21.3. Southern blotting analysis is the conventional test used to determinate the size of the repeats in the molecular diagnosis of DM2. However, the large number of CCTG repeats and their somatic instability complicates this diagnostic protocol. In order to improve the DM2 test, we have recently characterised a single nucleotide polymorphism located in the first intron of the ZNF9 gene. This SNP consists in a C to A nucleotide change, which creates or disrupts and ApaI enzyme restriction site, easily detectable by PCR amplification followed by restriction analysis. We genotyped this SNP in 30 unrelated DM2 patients and 70 unrelated Italians healthy individuals. Our results show that this polymorphism is in linkage disequilibrium with the DM2 mutation.

KW - Molecular diagnosis

KW - Myotonic dystrophy

KW - ZNF9

UR - http://www.scopus.com/inward/record.url?scp=11844264812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844264812&partnerID=8YFLogxK

U2 - 10.1016/j.mcp.2004.09.003

DO - 10.1016/j.mcp.2004.09.003

M3 - Article

C2 - 15652222

AN - SCOPUS:11844264812

VL - 19

SP - 71

EP - 74

JO - Molecular and Cellular Probes

JF - Molecular and Cellular Probes

SN - 0890-8508

IS - 1

ER -